Probiotics cannot treat or cure elevated cholesterol. What specific strains may do is support healthy cholesterol levels already in the normal range through mechanisms like bile salt hydrolase activity. L. reuteri NCIMB 30242 LRC™ has been studied in clinical trials examining cholesterol parameters in adults. Effects are strain-specific and modest. Probiotics are not a replacement for diet, exercise, or medication.

The strain matters more than the brand. Look for a fully named strain with published human clinical research on cholesterol or cardiovascular markers. Limosilactobacillus reuteri NCIMB 30242 LRC™ is one of the most researched strains for cholesterol parameters, selected for documented bile salt hydrolase activity. Strain selection matters — look for human clinical trial evidence on cholesterol parameters specifically. Bio-K+ Heart Health Probiotic Capsules feature L. reuteri NCIMB 30242 LRC™. Avoid products that list strains without species-level identification or clinical evidence.

Most clinical trials examining probiotics and cholesterol parameters run for 8 to 12 weeks. Consistency of daily intake matters far more than the specific time of day. Probiotics are not an immediate fix; frame them as daily-routine support for cholesterol levels already in the normal range. After the period your healthcare provider recommends, recheck your cholesterol panel together. Use that data to assess whether continued probiotic support fits your overall heart-health plan.

Probiotic supplements are generally well tolerated, but always speak to your healthcare provider before adding any supplement to a statin regimen. Probiotics are not a substitute for prescribed medication. No major probiotic-statin interactions have been documented in clinical literature, though individual health context always varies. The goal is to support healthy levels already in the normal range as part of a broader lifestyle approach.

Both drinkable and capsule probiotics can deliver effective live bacteria. What matters most is the specific strain. For Limosilactobacillus reuteri NCIMB 30242 LRC™, studied for cholesterol parameters, capsule format with targeted-release technology is the standard delivery mechanism. Bio-K+ Heart Health Capsules are designed for twice-daily, on-the-go use and are shelf-stable. Bio-K+ drinkables in the Original line target general digestive and flora health, not cardiovascular support. Choose based on strain and health goal.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.